Lena Gallagher, on Behalf of a Class v. Abbott Laboratories and Miles D. White
Case Details
- Judge(s)
- Posner, Easterbrook, Kanne
- Status — whether other courts must follow this ruling
- Published
- Procedural Posture — the stage the case had reached
- appeal
- Circuit
- Seventh Circuit
Related Laws
No specific laws identified for this ruling.
Outcome
The appellate court affirmed dismissal of securities fraud claims, holding that Abbott had no duty to disclose the FDA's regulatory position under the periodic disclosure system governing securities laws, and that plaintiffs failed to identify any false or misleading statements by Abbott.
Similar Rulings
Browse Related
Facing something similar at work?
Court rulings like this one are useful, but every situation is different. Take 3 minutes to see which laws may protect you — it's free, private, and no account is required to start.
This ruling information is sourced from public court records via CourtListener.com. Case outcomes, claim types, and summaries are extracted using AI analysis and may be incomplete or inaccurate. It is provided for informational and educational purposes only and does not constitute legal advice.
See something wrong, or named in this ruling and want it corrected or redacted? Request a correction.